BR9813318A - Process of treating tumors and macular degeneration in a human or veterinary patient, pharmaceutical composition for treating tumors and macular degeneration in a human or veterinary patient - Google Patents

Process of treating tumors and macular degeneration in a human or veterinary patient, pharmaceutical composition for treating tumors and macular degeneration in a human or veterinary patient

Info

Publication number
BR9813318A
BR9813318A BR9813318-7A BR9813318A BR9813318A BR 9813318 A BR9813318 A BR 9813318A BR 9813318 A BR9813318 A BR 9813318A BR 9813318 A BR9813318 A BR 9813318A
Authority
BR
Brazil
Prior art keywords
human
macular degeneration
veterinary patient
treating tumors
pharmaceutical composition
Prior art date
Application number
BR9813318-7A
Other languages
Portuguese (pt)
Inventor
Yat Sun Or
Jacob J Plattner
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of BR9813318A publication Critical patent/BR9813318A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

"PROCESSO DE TRATAMENTO DE TUMORES E DEGENERAçãO MACULAR EM PACIENTE HUMANO OU VETERINáRIO, COMPOSIçãO FARMACêUTICA PARA TRATAMENTO DE TUMORES E DEGENERAçãO MACULAR EM UM PACIENTE HUMANO OU VETERINáRIO". Um processo para o tratamento de tumores e degeneração macular em um paciente humano ou veterinário compreendendo a administração de um composto selecionado do grupo constituído de (I), (II), (III), (IV), (V), (VI), (VII), e uma composição farmacêutica compreendendo um veículo farmaceuticamente aceitável e um composto do grupo citado."TUMOR TREATMENT PROCESS AND MACULAR DEGENERATION IN HUMAN OR VETERINARY PATIENTS, PHARMACEUTICAL COMPOSITION FOR TREATMENT OF TUMORS AND MACULAR DEGENERATION IN A HUMAN OR VETERINARY PATIENT". A process for the treatment of tumors and macular degeneration in a human or veterinary patient comprising administering a compound selected from the group consisting of (I), (II), (III), (IV), (V), (VI) , (VII), and a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of the aforementioned group.

BR9813318-7A 1997-10-31 1998-10-30 Process of treating tumors and macular degeneration in a human or veterinary patient, pharmaceutical composition for treating tumors and macular degeneration in a human or veterinary patient BR9813318A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96147397A 1997-10-31 1997-10-31
PCT/US1998/023043 WO1999022722A2 (en) 1997-10-31 1998-10-30 Use of macrolides for the treatment of cancer and macular degeneration

Publications (1)

Publication Number Publication Date
BR9813318A true BR9813318A (en) 2000-08-22

Family

ID=25504514

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9813318-7A BR9813318A (en) 1997-10-31 1998-10-30 Process of treating tumors and macular degeneration in a human or veterinary patient, pharmaceutical composition for treating tumors and macular degeneration in a human or veterinary patient

Country Status (17)

Country Link
EP (1) EP1027060A2 (en)
JP (1) JP2001521891A (en)
KR (1) KR20010031577A (en)
CN (1) CN1278178A (en)
AR (1) AR043071A1 (en)
AU (1) AU1206799A (en)
BG (1) BG104436A (en)
BR (1) BR9813318A (en)
CA (1) CA2307850A1 (en)
HU (1) HUP0100012A3 (en)
IL (1) IL135518A0 (en)
NO (1) NO20002189L (en)
PL (1) PL340604A1 (en)
SK (1) SK6172000A3 (en)
TR (1) TR200001147T2 (en)
WO (1) WO1999022722A2 (en)
ZA (1) ZA989885B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60140936D1 (en) 2000-04-13 2010-02-11 Biotica Tech Ltd GLYCOSYLATED HYBRID COMPOUNDS, THEIR PREPARATION AND USE
WO2004027027A2 (en) 2002-09-18 2004-04-01 Trustees Of The University Of Pennsylvania Method of inhibiting choroidal neovascularization
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
WO2004087672A1 (en) 2003-03-28 2004-10-14 Cornell Research Foundation, Inc. Migrastatin analog compositions and uses thereof
US7083802B2 (en) 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
US7087237B2 (en) * 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
CN1950388A (en) * 2004-02-27 2007-04-18 瑞伯-X医药品有限公司 Macrocyclic compounds and methods of making and using the same
JP5383037B2 (en) * 2004-02-27 2014-01-08 リブ−エックス ファーマシューティカルズ，インコーポレイテッド Macrocyclic compounds and methods of making and using them
WO2006001967A2 (en) 2004-05-25 2006-01-05 Sloan-Kettering Institute For Cancer Research Migrastatin analogs in the treatment of cancer
EP1805161B1 (en) 2004-09-23 2014-05-07 Sloan-Kettering Institute For Cancer Research Isomigrastatin analogs in the treatment of cancer
JP2008530127A (en) 2005-02-09 2008-08-07 マクサイト， インコーポレイテッド Formulation for eye treatment
CA2615990A1 (en) 2005-07-18 2007-01-25 Minu, L.L.C. Enhanced ocular neuroprotection/neurostimulation
JP2009506063A (en) 2005-08-24 2009-02-12 リブ−エックス ファーマシューティカルズ，インコーポレイテッド Triazole compounds and methods for making and using the same
EP1928893A2 (en) 2005-08-24 2008-06-11 Rib-X Pharmaceuticals, Inc. Triazole compounds and methods of making and using the same
AU2007212271B2 (en) 2006-02-09 2012-11-01 Santen Pharmaceutical Co., Ltd. Stable formulations, and methods of their preparation and use
WO2007112052A2 (en) 2006-03-23 2007-10-04 Macusight, Inc. Formulations and methods for vascular permeability-related diseases or conditions
CN106317146B (en) * 2015-06-18 2019-06-21 沈阳药科大学 Bicyclic clarithomycin derivative and its as tumour cell increment inhibitor purposes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6461090A (en) * 1989-10-30 1991-05-02 Abbott Laboratories Injectable formulation for lipophilic drugs
US5498424A (en) * 1994-11-30 1996-03-12 Klein; Ira Method of treating obesity

Also Published As

Publication number Publication date
EP1027060A2 (en) 2000-08-16
TR200001147T2 (en) 2000-08-21
AU1206799A (en) 1999-05-24
WO1999022722A3 (en) 1999-08-05
IL135518A0 (en) 2001-05-20
BG104436A (en) 2000-12-29
HUP0100012A2 (en) 2001-05-28
ZA989885B (en) 1999-05-05
NO20002189D0 (en) 2000-04-27
JP2001521891A (en) 2001-11-13
SK6172000A3 (en) 2001-03-12
CN1278178A (en) 2000-12-27
HUP0100012A3 (en) 2003-07-28
AR043071A1 (en) 2005-07-20
PL340604A1 (en) 2001-02-12
KR20010031577A (en) 2001-04-16
CA2307850A1 (en) 1999-05-14
NO20002189L (en) 2000-06-28
WO1999022722A2 (en) 1999-05-14

Similar Documents

Publication Publication Date Title
BR9813318A (en) Process of treating tumors and macular degeneration in a human or veterinary patient, pharmaceutical composition for treating tumors and macular degeneration in a human or veterinary patient
BR9813373A (en) Compound, process for preparing it, pharmaceutical composition, process for preparing it, use of a compound, and, processes for effecting immunosuppression and for treating or reducing the risk of reversibly obstructive airway disease in a patient
ATE307608T1 (en) COMBINATION OF DOCTAXEL AND RHUMAB HER2 FOR CANCER TREATMENT
HUT76258A (en) Compositions comprising dna damaging agents and p53, and methods for uses thereof
BR0209658A (en) 4-Amino-5-phenyl-7-1-cyclobutyl-pyrrolo [2,3-d] pyrimidine derivatives
BR9715022A (en) Method for treating prostate disease using systematic and / or prolonged release of vitamin D formulations
DE69127175T2 (en) Antisense oligonucleotides for the treatment of cancer
DE69533112T2 (en) USE OF FLAVOLIGNANES FOR THE PRODUCTION OF MEDICINES WITH ANTIPROLIFERATIVE ACTIVITY IN UTERUS, BREAST, EGGS
BG101118A (en) Therapeutical compounds
BR9908510A (en) Use of a compound, compound, process for preparing a compound, pharmaceutical composition, and process for treating a patient suffering from, or at risk for, a mycobacterial disease
BR9500436A (en) Products use of a g-csf use of a tnf protein ligand process for the treatment and / or prevention of septic shock
BR9814419A (en) "combination of benzocycloheptapyridine compounds and antineoplastic drugs for the treatment of proliferative diseases"
ATE334589T1 (en) ANTI-ARRHYTHMIC COMPOSITIONS AND TREATMENT METHODS
PT1237562E (en) PROCESS OF PREPARATION OF MYCANYAN EXTRACTS CONTAINING MICANOLIDE AND DIHYDROMICANOLID AND USES IN THE TREATMENT OF PROLIFERATIVE DISEASES
MXPA00010254A (en) The treatment of sexual dysfunction in certain patient groups.
PT1076561E (en) COMBINATION THERAPY FOR THE TREATMENT OF TUMORS
DE69314586D1 (en) Medicament composition containing TCF-II
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
BR0014751A (en) Compound, stereoisomer or mixture of stereoisomers, pharmaceutical composition, method of treating a patient in need of antimicrobial treatment, and use of a compound
KR900017599A (en) Pharmaceutical composition for tumor treatment
BR9810930A (en) Pharmaceutical compositions of arglabine and arglabine derivatives

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI.